Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Mechanisms of immune tolerance to allergens in children

  • Kucuksezer, Umut C. (Department of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University) ;
  • Ozdemir, Cevdet (Department of Pediatric Allergy, Atasehir Hospital, Memorial Health Group) ;
  • Akdis, Mubeccel (Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich) ;
  • Akdis, Cezmi A. (Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich)
  • 투고 : 2013.10.31
  • 심사 : 2013.11.11
  • 발행 : 2013.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Because the prevalence of allergic diseases has significantly increased in recent years, understanding the causes and mechanisms of these disorders is of high importance, and intense investigations are ongoing. Current knowledge pinpoints immune tolerance mechanisms as indispensable for healthy immune response to allergens in daily life. It is evident that development and maintenance of allergen-specific T cell tolerance is of vital importance for a healthy immune response to allergens. Such tolerance can be gained spontaneously by dose-dependent exposures to allergens in nature or by allergen-specific immunotherapy. Allergen-specific immunotherapy induces regulatory T cells with the capacity to secrete interleukin-10 and transforming growth factor-${\beta}$, limits activation of effector cells of allergic inflammation (such as mast cells and basophils), and switches antibody isotype from IgE to the noninflammatory type IgG4. Although allergen-specific immunotherapy is the only method of tolerance induction in allergic individuals, several factors, such as long duration of treatment, compliance problems, and life-threatening side effects, have limited widespread applicability of this immunomodulatory treatment. To overcome these limitations, current research focuses on the introduction of allergens in more efficient and safer ways. Defining the endotypes and phenotypes of allergic diseases might provide the ability to select ideal patients, and novel biomarkers might ensure new custom-tailored therapy modalities.

키워드

참고문헌

  1. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013;131:1288-96.e3. https://doi.org/10.1016/j.jaci.2013.01.049
  2. Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 2009;8:645-60. https://doi.org/10.1038/nrd2653
  3. Akdis CA, Blaser K, Akdis M. Genes of tolerance. Allergy 2004; 59:897-913. https://doi.org/10.1111/j.1398-9995.2004.00587.x
  4. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-${\gamma}$: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011;127:701-21.e1-70. https://doi.org/10.1016/j.jaci.2010.11.050
  5. Blaser K, Carballido J, Faith A, Crameri R, Akdis C. Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Int Arch Allergy Immunol 1998;117:1-10.
  6. Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol 2006;18:718-26. https://doi.org/10.1016/j.coi.2006.09.016
  7. Jutel M, Blaser K, Akdis CA. Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 2005;137: 82-92. https://doi.org/10.1159/000085108
  8. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 2006;18:738-44. https://doi.org/10.1016/j.coi.2006.06.003
  9. Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Specific immunotherapy and turning off the T cell: how does it work? Ann Allergy Asthma Immunol 2011;107:381-92. https://doi.org/10.1016/j.anai.2011.05.017
  10. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergenspecific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567-75. https://doi.org/10.1084/jem.20032058
  11. Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999;103: 1173-9. https://doi.org/10.1016/S0091-6749(99)70195-8
  12. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-75. https://doi.org/10.1056/NEJM199908123410702
  13. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006;6:761-71. https://doi.org/10.1038/nri1934
  14. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780-91. https://doi.org/10.1016/j.jaci.2007.01.022
  15. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
  16. Ozdemir C, Akdis M, Akdis CA. T regulatory cells and their counterparts: masters of immune regulation. Clin Exp Allergy 2009;39:626-39. https://doi.org/10.1111/j.1365-2222.2009.03242.x
  17. Thunberg S, Akdis M, Akdis CA, Gronneberg R, Malmström V, Trollmo C, et al. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls. Clin Exp Allergy 2007;37:1127-36. https://doi.org/10.1111/j.1365-2222.2007.02739.x
  18. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn- Schmid B, Ebner C. Sublingual immunotherapy induces IL-10- producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007;120:707-13. https://doi.org/10.1016/j.jaci.2007.06.013
  19. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-14. https://doi.org/10.1002/eji.200322919
  20. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 2008; 121:1467-72, 1472.e1. https://doi.org/10.1016/j.jaci.2008.03.013
  21. Soyer OU, Akdis M, Ring J, Behrendt H, Crameri R, Lauener R, et al. Mechanisms of peripheral tolerance to allergens. Allergy 2013;68:161-70. https://doi.org/10.1111/all.12085
  22. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011;127:18-27. https://doi.org/10.1016/j.jaci.2010.11.030
  23. Aslam A, Chan H, Warrell DA, Misbah S, Ogg GS. Tracking antigen- specific T-cells during clinical tolerance induction in humans. PLoS One 2010;5:e11028. https://doi.org/10.1371/journal.pone.0011028
  24. Oral HB, Kotenko SV, Yilmaz M, Mani O, Zumkehr J, Blaser K, et al. Regulation of T cells and cytokines by the interleukin-10 (IL- 10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006;36:380-8. https://doi.org/10.1002/eji.200425523
  25. Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 2008;224:166-82. https://doi.org/10.1111/j.1600-065X.2008.00662.x
  26. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+) CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302. https://doi.org/10.1084/jem.192.2.295
  27. Letterio JJ, Roberts AB. Regulation of immune responses by TGFbeta. Annu Rev Immunol 1998;16:137-61. https://doi.org/10.1146/annurev.immunol.16.1.137
  28. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-86. https://doi.org/10.1084/jem.20030152
  29. Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 2004173:6526-31. https://doi.org/10.4049/jimmunol.173.11.6526
  30. Palomares O, O'Mahony L, Akdis CA. The many routes of dendritic cells to ensure immune regulation. J Allergy Clin Immunol 2011; 127:1541-2. https://doi.org/10.1016/j.jaci.2011.04.002
  31. Bonasio R, von Andrian UH. Generation, migration and function of circulating dendritic cells. Curr Opin Immunol 2006;18:503-11. https://doi.org/10.1016/j.coi.2006.05.011
  32. Novak N, Koch S, Allam JP, Bieber T. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. J Allergy Clin Immunol 2010;125:50-9. https://doi.org/10.1016/j.jaci.2009.11.019
  33. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-9. https://doi.org/10.1084/jem.194.6.863
  34. Kucuksezer UC, Palomares O, Ruckert B, Jartti T, Puhakka T, Nandy A, et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol 2013;131:875-85. https://doi.org/10.1016/j.jaci.2012.10.051
  35. Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E, et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol 2012;129:510-20, 520. e1-9. https://doi.org/10.1016/j.jaci.2011.09.031
  36. Sackesen C, van de Veen W, Akdis M, Soyer O, Zumkehr J, Ruckert B, et al. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides. Allergy 2013;68:593-603. https://doi.org/10.1111/all.12133
  37. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31. https://doi.org/10.1038/90667
  38. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003;197:489-501. https://doi.org/10.1084/jem.20021293
  39. Deniz G, Akdis M, Aktas E, Blaser K, Akdis CA. Human NK1 and NK2 subsets determined by purification of IFN-gammasecreting and IFN-gamma-nonsecreting NK cells. Eur J Immunol 2002;32:879-84. https://doi.org/10.1002/1521-4141(200203)32:3<879::AID-IMMU879>3.0.CO;2-2
  40. Deniz G, Erten G, Kucuksezer UC, Kocacik D, Karagiannidis C, Aktas E, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008;180:850-7. https://doi.org/10.4049/jimmunol.180.2.850
  41. van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Sollner S, Akdis DG, et al. IgG4 production is confined to human IL-10- producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 2013;131:1204-12. https://doi.org/10.1016/j.jaci.2013.01.014
  42. Taylor A, Akdis M, Joss A, Akkoc T, Wenig R, Colonna M, et al. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol 2007;120:76-83. https://doi.org/10.1016/j.jaci.2007.04.004
  43. Taylor A, Verhagen J, Akkoc T, Wenig R, Flory E, Blaser K, et al. IL-10 suppresses CD2-mediated T cell activation via SHP-1. Mol Immunol 2009;46:622-9. https://doi.org/10.1016/j.molimm.2008.07.031
  44. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20. https://doi.org/10.1084/jem.174.5.1209
  45. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin- 10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765. https://doi.org/10.1146/annurev.immunol.19.1.683
  46. Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly RP, et al. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999;93:1456-63.
  47. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996;98:1676-83. https://doi.org/10.1172/JCI118963
  48. Soyer OU, Akdis M, Akdis CA. Mechanisms of subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am 2011; 31:175-90. https://doi.org/10.1016/j.iac.2011.02.006
  49. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102: 98-106. https://doi.org/10.1172/JCI2250
  50. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008;63:1455-63. https://doi.org/10.1111/j.1398-9995.2008.01774.x
  51. James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011;127:509-16.e1-5. https://doi.org/10.1016/j.jaci.2010.12.1080
  52. van Neerven RJ, Arvidsson M, Ipsen H, Sparholt SH, Rak S, Wurtzen PA. A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 2004;34:420-8. https://doi.org/10.1111/j.1365-2222.2004.01899.x
  53. Jutel M, Klunker S, Akdis M, MaIolepszy J, Thomet OA, Zak- Nejmark T, et al. Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol 2001;124: 190-2. https://doi.org/10.1159/000053707
  54. Jutel M, Akdis CA. Immunological mechanisms of allergenspecific immunotherapy. Allergy 2011;66:725-32. https://doi.org/10.1111/j.1398-9995.2011.02589.x
  55. Platts-Mills TA, Woodfolk JA. Allergens and their role in the allergic immune response. Immunol Rev 2011;242:51-68. https://doi.org/10.1111/j.1600-065X.2011.01021.x
  56. Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena- Cagnani CE, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012;130:1049-62. https://doi.org/10.1016/j.jaci.2012.07.053
  57. Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy 2011; 41:1226-34. https://doi.org/10.1111/j.1365-2222.2011.03812.x
  58. Arikan C, Bahceciler NN, Deniz G, Akdis M, Akkoc T, Akdis CA, et al. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004;34:398-405. https://doi.org/10.1111/j.1365-2222.2004.01869.x
  59. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008;205:2887-98. https://doi.org/10.1084/jem.20080193
  60. Akdis CA, Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol 2000;121:261-9. https://doi.org/10.1159/000024352
  61. Kussebi F, Karamloo F, Rhyner C, Schmid-Grendelmeier P, Salagianni M, Mannhart C, et al. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. J Allergy Clin Immunol 2005;115:323-9. https://doi.org/10.1016/j.jaci.2004.11.041
  62. Crameri R, Fluckiger S, Daigle I, Kundig T, Rhyner C. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Allergy 2007;62:197-206.
  63. Senti G, Crameri R, Kuster D, Johansen P, Martinez-Gomez JM, Graf N, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 2012;129:1290-6. https://doi.org/10.1016/j.jaci.2012.02.026
  64. Hylander T, Latif L, Petersson-Westin U, Cardell LO. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol 2013;131:412-20. https://doi.org/10.1016/j.jaci.2012.10.056
  65. Vallery-Radot P, Hangenau J. Asthme d'origine equine. Essai de desensibilisation par des cutireactions repetees. Bull Soc Med Hop Paris 1921;45:1251-60.
  66. Senti G, von Moos S, Tay F, Graf N, Sonderegger T, Johansen P, et al. Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol 2012;129:128-35. https://doi.org/10.1016/j.jaci.2011.08.036
  67. Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy 2010;65:410-1. https://doi.org/10.1111/j.1398-9995.2009.02189.x
  68. Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2013; 131:1479-90. https://doi.org/10.1016/j.jaci.2013.02.036
  69. Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008;63:842-53. https://doi.org/10.1111/j.1398-9995.2008.01715.x

피인용 문헌

  1. Immunotherapy in allergy and cellular tests : State of art vol.10, pp.6, 2013, https://doi.org/10.4161/hv.28592
  2. Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome vol.174, pp.11, 2013, https://doi.org/10.1007/s00431-015-2553-1
  3. Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma vol.7, pp.None, 2016, https://doi.org/10.3389/fimmu.2016.00620
  4. Precision/Personalized Medicine in Allergic Diseases and Asthma vol.66, pp.6, 2018, https://doi.org/10.1007/s00005-018-0526-6
  5. Newly identified T cell subsets in mechanistic studies of food immunotherapy vol.129, pp.4, 2019, https://doi.org/10.1172/jci124605
  6. Utility of neonatal donors in pediatric liver transplantation: A single‐center experience vol.23, pp.5, 2013, https://doi.org/10.1111/petr.13396
  7. Pharmacological Effects of Novel Peptide Drugs on Allergic Rhinitis at the Small Ribonucleic Acids Level vol.11, pp.None, 2020, https://doi.org/10.3389/fgene.2020.560812
  8. EAACI Allergen Immunotherapy User's Guide vol.31, pp.suppl, 2013, https://doi.org/10.1111/pai.13189